Skip to content

Illumina

US · ILMN #539 by market cap Listed 1970
192.82 -7.84 -3.90%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Price chart

Pre-market 198.07 -1.29%
After-hours 193.00 +0.09%
Overnight 199.27 -0.69%
293.69145.23192.822026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on ILMN?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Bullish
  • Recent price momentum is +26.1% on average (3-month/1-year).
  • Main-fund capital flow has been a net inflow over the last 45 sessions.
  • Short interest has risen to 5.3% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Bearish
  • Price is below its 20-day average and below its 60-day average.
  • The 20-day average is below the 60-day average, a short-term downtrend.
Quant Rating, last 30 days B → C

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2848 U.S. stocks StockVane covers.

Last computed: 2026-11-22 08:27 UTC

Data coverage: 6 of 6 factors. Missing data is not a zero score.

Overall B
ValuationGrowthProfitMomentumHealthAnalyst
Valuation D-

How expensive the stock is versus earnings, sales and its own 5-year history.

P/E (TTM) 33.2x Better than 19%
Forward P/E 34.0x Better than 14%
Price / Sales 6.4x Better than 17%
P/E vs own 5-yr range 77th pctl Better than 29%
Growth B-

How fast revenue, profit and free cash flow are compounding.

Revenue CAGR (3Y) -1.8% Better than 19%
Net income CAGR (3Y) -2.7% Better than 37%
Free cash flow CAGR (3Y) 106.3% Better than 94%
Profitability A

How much profit the business keeps from each dollar of sales and capital.

Gross margin 66.1% Better than 80%
Operating margin 18.8% Better than 74%
Net margin 19.6% Better than 79%
Return on equity 33.4% Better than 89%
Return on invested capital 17.5% Better than 87%
Momentum B+

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return -12.1% Better than 46%
6-month return 33.5% Better than 91%
12-month return (ex latest month) 117.5% Better than 96%
Distance below 52-week high 37.7% Better than 31%
Financial Health B-

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 2.1x Better than 58%
Debt to assets 38.4% Better than 29%
Interest coverage 11.8x Better than 75%
Free cash flow / net income 109.5% Better than 45%
Analyst View C+

What the Street thinks: share of Buy ratings and upside to the average target.

Analysts rating Buy 53.3% Better than 32%
Upside to average target 37.8% Better than 58%

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W -6.85%
1M -28.03%
3M -9.58%
6M +35.87%
YTD +47.01%
1Y +61.68%
3Y +103.07%
5Y -47.75%

Key statistics

Price & volume

Prev close
200.66
Open
197.57
Day range
191.25 - 199.24
Avg price
193.86
Volume
1.95M
Turnover
378.82M
Amplitude
3.98%
52-week range
112.65 - 309.35

Valuation

P/E
35.38
P/E (TTM)
33.19
P/B
9.27
EPS
5.45
Net profit
824.04M
Net assets
3.14B

Share structure

Market cap
29.15B
Float cap
29.06B
Shares out
151.20M
Float shares
150.73M

Dividend & listing

Dividend (TTM)
0.00
Listing date
1970-01-01
52-week range 41% of range
112.65 309.35

37.7% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

+28.43M net over the window

Short interest

Shares short
8.02M
As of
2026-10-30

Frequently asked questions

What is the current stock price of Illumina (ILMN)?

Illumina last traded at 192.82. This page shows a periodic quote snapshot. Check the displayed quote time.

What is Illumina's market cap?

About 29.15B.

What is the P/E ratio of Illumina?

The trailing twelve-month P/E is 33.19. The Valuation tab shows it against the stock's own five-year range.

Does Illumina pay a dividend?

Illumina does not currently pay a regular dividend.

Is Illumina a buy according to analysts?

The consensus of 15 analysts is a Buy rating, with an average 12-month price target of 265.73, which implies 37.8% upside from the current price. This is not investment advice.

What is Illumina's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Illumina a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.

Quote time 2026-11-20 19:30:00 · For reference only, not investment advice and not tailored to your situation.

Illumina discussion 0 comments

Add a comment